Human granulocyte-macrophage colony-stimulating factor (GM-CSF) and interleukin-3 (IL-3) exert multiple effects on the proliferation, differentiation, and function of myeloid lineage cells through their interaction with specific cellsurface receptors. There is a considerable degree of overlap in the biological effects of these two growth factors, but little is known about the mechanisms of postreceptor signal transduction. We have investigated the effects of GM-CSF and IL-3 on protein tyrosine-kinase activity in a human cell line, M07E. which proliferates in response t o either factor. Tyrosine-kinase activity was detected using immunoblotting with a monoclonal antibody (MoAb) specific for phosphotyrosine. GM-CSF and IL-3 were found t o induce a nearly identical pattern of protein tyrosine phosphorylation using both one-and two-dimensional gel electrophoresis. Tyrosine phosphorylation of t w o cytosolic proteins in particular was increased more than 10-fold, a 93-Kd protein (pp93) and a 70-Kd protein (pp70). Tyrosine phosphorylation of pp93 and pp70 was observed within 1 minute, reached a maximum at 5 t o 15 minutes, and gradually decreased thereafter. Other proteins of 150, 125, 63, 55, 42, and 36 Kd were also phosphorylated on tyrosine in response t o both OM-CSF and IL-3, although t o RANULOCYTE-macrophage colony-stimulating fac-G tor (GM-CSF) and interleukin-3 (IL-3) are members of a family of hematopoietic growth factors that stimulate the proliferation, differentiation, and activation of blood cells and their precursors.' There is a considerable degree of overlap in target-cell specificity and functional effects of GM-CSF and IL-3, particularly on immature myeloid cells. Radiolabeled ligands have been used in a number of studies to identify and to characterize cell-surface receptors for GM-CSF and IL-3.2-6 High-affinity GM-CSF receptors (Kd = 30 to 100 pmol/L) are widely expressed by hematopoietic cells, with mature neutrophils expressing the highest number of receptors (500 to 600/cell) and immature leukemic cell lines the least (20 to 200 receptors/cell).2 Crosslinking studies have suggested that the GM-CSF receptor has an apparent mol wt of 84 Kd.5 IL-3 receptors are also widely distributed on normal and leukemic myeloid cells and . interleukin-6 (IL-6). interferon y, tumor necrosis factor (TNF), or transforming growth factor-@ (TGF-B) did not induce tyrosine phosphorylation of pp93 or pp70, suggesting that these two phosphoproteins are specific for GM-CSF-or IL-3-induced activation. The extent and duration of phosphorylation of all the substrates were increased by pretreatment of cells with vanadate, an inhibitor of protein-tyrosine phosphatases. Importantly, culture of M07E cells with vanadate (up tQ 10 pmol/L) resulted in a dose-dependent increase in GM-CSF-or IL-3-induced proliferation of up t o 1.8-fold. These results suggest that tyrosine phosphorylation may be important for GM-CSF and IL-3 receptor-mediated signal transduction and that cell proliferation may be, at least partially, regulated by a balance between CSFinduced protein-tyrosine kinase activity and proteintyrosine phosphatase activity.
a lesser degree. Tyrosine phosphorylation was dependent on the concentration of GM-CSF over the range of 0.1 t o 10 ng/mL and on IL-3 over the range of 1 t o 30 ng/mL. Stimulation of M07E cells with 12-0-tetradecanoyl-phorbol-13-acetate (TPA) or cytokines such as G-CSF, M-CSF, interleukin-I (IL-I 1, interleukin-4 (IL-4). interleukin-6 (IL-6). interferon y, tumor necrosis factor (TNF), or transforming growth factor-@ (TGF-B) did not induce tyrosine phosphorylation of pp93 or pp70, suggesting that these two phosphoproteins are specific for GM-CSF-or IL-3-induced activation. The extent and duration of phosphorylation of all the substrates were increased by pretreatment of cells with vanadate, an inhibitor of protein-tyrosine phosphatases. Importantly, culture of M07E cells with vanadate (up tQ 10 pmol/L) resulted in a dose-dependent increase in GM-CSF-or IL-3-induced proliferation of up t o 1.8-fold. These results suggest that tyrosine phosphorylation may be important for GM-CSF and IL-3 receptor-mediated signal transduction and that cell proliferation may be, at least partially, regulated by a balance between CSFinduced protein-tyrosine kinase activity and proteintyrosine phosphatase activity. 0 1990 by The American Society of Hematology.
have been reported to have a mol wt of approximately 140 Kd.6*7 GM-CSF and IL-3 are not closely related at the amino acid level, and initial studies of murine and human hematopoietic cells have suggested that the receptors for GM-CSF and IL-3 are distinct.*-" For example, the neutrophil has been shown to express GM-CSF receptors but not IL-3 receptors." Recently, however, GM-CSF and IL-3 have been shown to partially cross-compete with each other for binding to receptors on KG-1 cells and some fresh leukemic cells>" possibly suggesting that the receptor(s) for these two factors may be physically associated in some cell types or that a common ligand-binding site may exist.
The mechanisms of signal transduction from the GM-CSF and IL-3 receptors are not well understood. In the neutrophil, GM-CSF enhances superoxide production when the cells are induced by agents such as fMLP.12 This priming does not occur directly as a result of increased calcium flux or activation of protein kinase C13 but is associated with enhanced N a + + influx, release of arachidonic acid, and generation lipoxygenase products such as leukotriene B4.I3-l5 These effects are inhibited by pertussis toxin, suggesting that priming is coupled to the receptor by a G protein.I5 IL-3 receptor signal transduction has not been extensively studied. Recently, however, both IL-3 and GM-CSF have been shown to induce tyrosine phosphorylation of several proteins in murine FDC-P1, IC-2.9,32Dc115, or B6SUtA, cell line^,','^-^^ and GM-CSF has been shown to induce tyrosine phosphorylation in human neutrophil^,'^ suggesting that receptor activation induces tyrosine-kinase activity. Evidence that tyrosine phosphorylation is important for proliferation comes from observations that introduction of a known tyrosinekinase receptor, such as the epidermal growth factor (EGF) receptor, can convert an IL-34ependent murine cell line to EGF-dependence" and also from the finding that factordependent cell lines can be converted to factor independence by oncogenes containing tyrosine kinases." c D N A s encoding a low-affinity human GM-CSF and a low-affinity murine IL-3 receptor have recently been c l~n e d .~~.~~ The predicted amino-acid sequences of the receptors suggests that they are not tyrosine kinases, and thus the mechanism leading to activation of cellular tyrosine kinases by these factors is uncertain.
In this study we have investigated GM-CSF-and IL-3-inducible tyrosine-kinase activity in a unique, factordependent, human megakaryoblastic leukemia cell line, M07E," which proliferates in response to either human GM-CSF or IL-3 but not to human G-CSF, interleukin-1 (IL-1), or M-CSF. Using an immunoblot technique with a monoclonal antibody (MoAb) specific for phosphotyrosine, it is demonstrated that there is rapid, dose-dependent tyrosine phosphorylation of similar sets of substrate proteins in response to physiologic concentrations of either GM-CSF or IL-3 but not in response to a variety of other hematopoietins or to activation of protein-kinase C by 12-0-tetradecanoylphorbol-13-acetate (TPA). Furthermore, the degree of tyrosine phosphorylation can be increased by pretreatment of M 0 7 E cells with the protein-tyrosine phosphatase (PTPase) inhibitor vanadate. This pretreatment does not induce proliferation by itself but does result in a dose-dependent increase in CSF-dependent proliferation. These results suggest that both GM-CSF and IL-3 induce tyrosine phosphorylation of an identical or overlapping set of cellular proteins and further suggest that this may be functionally important in factor-dependent proliferation.
MATERIALS AND METHODS

Reagents.
Recombinant human (rh) GM-CSF, IL-3, G-CSF, interleukin-4 (IL-4), interleukin-6 (IL-6), and M-CSF were gifts from Drs Steven Clark and Gordon Wong, Genetics Institute, Cambridge, MA. GM-CSF, IL-3, and M-CSF were highly purified, while other factors were in the form of media from transfected CHO cells. Recombinant IL-lB was purchased from Genzyme Corporation (Boston, MA), and recombinant TNF was a gift from Asahi Chemical Co, (Shiznuka, Japan). Recombinant human interferon-? was a gift from Biogen. TGFB and platelet-derived growth factor (PDGF) were purchased from Collaborative Research (Waltham, MA). Phorbol myristate acetate (PMA), bovine serum albumin (BSA; fraction V), o-phosphotyrosine, and sodium orthovanadate were purchased from Sigma (St. Louis, MO).
The antiphosphotyrosine antibody is a murine MoAb generated using phosphotyramine as the immunogen (Druker et al, unpublished data, February 1989). This antibody is specific for tyrosinephosphorylated proteins and does not cross-react with phosphoserine, phosphotheronine, phosphohistidine, or tyrosine sulfate. When used for immunoblotting, the addition of 1 mmol/L phosphotyrosine completely eliminates all immunoreactive bands, while phosphothreonine or phosphoserine have no effect. Anti-GM-CSF antibody (3092) is a murine MoAb that neutralizes human natural and recombinant GM-CSF (Y. Kanakura and J.D. Griffin, manuscript in preparation).
Normal peripheral blood and bone marrow cells were obtained from healthy adult volunteers, and mononuclear cells were prepared by Ficoll-Hypaque density gradiNormal and leukemic cells. ent centrifugation. Monocytes were prepared from blood mononuclear cells by removing E rosetting cells and then collecting plastic adherent cells as previously described.' Granulocytes were prepared from Ficoll-Hypaque pellets by dextran sedimentation as previously de~cribed'~ and were greater than 99% granulocytes by morphological analysis and immunofluorescent staining with a MoAb reactive with a granulocyte-specific epitope of FcRIII (CD16; J. Griffin, unpublished data, July 1988).
Blood or marrow aspirate samples were obtained at diagnosis from adult patients with acute myelogenous leukemia (AML). The diagnosis of those leukemias was established by morphology, cytochemical staining, and surface-marker analysis using a panel of MoAbs. Leukemic cells were recovered by Ficoll-Hypaque densitygradient sedimentation, and mononuclear cells were cyropreserved in 10% dimethylsulfoxide in the vapor phase of liquid nitrogen until use. After thawing, samples selected for study were required to have a viability of leukemic cells of greater than 90%. All tissue samples were obtained after informed consent of donors and under institutional review board approved protocols.
The human GM-CSF and IL-34ependent cell line, M07E, was obtained from Dr Steve Clark, Genetics Institute, and was originally derived by Avanzi et a1 from the peripheral blood of an infant with acute megakaryocytic le~kemia.'~ The cell line was cultured in RPMI 1640 medium (Gibco, Grand Island, NY) supplemented with 10% fetal bovine serum (FBS), rh GM-CSF, 10 ng/mL, or rh IL-3, 10 ng/mL. Human myeloid leukemia cell lines HL60 and THP-1 were obtained from the American-Type Culture Collection (Rockville, MD). Characterization of the human myeloid leukemia cell line, JOSK-M, was reported previously.26 HL-60, THP-1, and JOSK-M were cultured in RPMI 1640 containing 10% FBS. MTT [3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide; Sigma] incorporation was used to quantitate factorinduced proliferation of M07E cells as previously described.*' Briefly, triplicate aliquots of M07E cells were cultured in flatbottom microtiter plates (100 pL/well) for 72 hours at 37OC. MTT was added for the final 4-hour of culture (10 pL of a 5 mg/mL solution of MTT in phosphate-buffered saline [PBS]). At 72-hours. 100 pL of acid isopropanol (0.04 N HCl in isopropanol) was added to all wells, mixed, and the optical density measured on a microelisa plate reader at 540 nm. This assay has been more reproducible and reliable than 'H-thymidine incorporation or cell enumeration, although equivalent results are obtained with all three assays.
Exponentially growing M07E cells were washed free of serum and growth factors and incubated in serum-free RPMI 1640 containing 0.5% BSA for 6 to 18 hours at 37OC to factor deprive the cells. In some experiments sodium orthovanadate (0.8 to 20 pmol/L) was added for the last 2 to 3 hours of culture. The cells were then exposed to various factors at 37OC for 30 seconds to 120 minutes. Other leukemic cell lines and normal and primary leukemic cells were washed twice with serumfree medium and exposed to growth factors. After stimulation, cells were washed with cold PBS and lysed in Lysis Buffer (20 mmol/L tris-HC1, pH 8.0, 137 mmol/L NaCI, 10% glycerol, 1% Nonidet P-40) containing 1 mmol/L phenyl methylsulfonyl flouride (PMSF, Sigma), 0.15 U/mL aprotonin (Sigma), 10 mmol/L EDTA, 10 pg/mL leupeptin (Sigma), 100 mmol/L sodium fluoride, and 2 mmol/L sodium orthovanadate at 4OC for 20 minutes. Insoluble material was removed by centrifugation at 4OC for 15 minutes at 10,ooog.
Cytosol and membrane fractions were prepared according to the method of Koyasu et aLzo Briefly, the cells stimulated with growth factors were pelleted by centrifugation, snap frozen in a dry ice-acetone bath, and thawed in lysis buffer containing protease and phosphatase inhibitors as described above but without detergent. The cells were then homogenized, subjected to three cycles of
Cell lines.
Stimulation with factors and cell lysis.
For personal use only. on October 3, 2017. by guest www.bloodjournal.org From freezing and thawing, and centrifuged at 1O.OOOg for 30 minutes. The supernatant cytosol fraction was mixed with 1/10 vol of 10% NP-40. The pellets were suspended in lysis buffer containing NP-40. Insoluble material was then removed from the lysate containing membrane proteins by centrifugation. Total protein content of the lysate was determined by the Bio-Rad protein assay.
Lysates (-150 pg for 13 x 12-cm gelsand 40pg for 8 x 7.5-cm minigels) were mixed 1:1 with 2 x sodium dodecyl sulfate (SDS) sample buffer with (reducing) or without (nonreducing) 2-mercaptoethanol and heated a t 1 OOOC for 5 minutes prior to one-dimensional SDS-polyacrylamide gel electrophoresis (SDS-PAGE) with 7.5% polyacrylamide. In some experiments sections from nonreducing gels were excised and applied horizontally to the top of a second gel. which was then run under reducing conditions. After electrophoresis. proteins were electrophoretically transferred from the gel onto a 0. Peptide mapping was undertaken in two ways. First, M07E cells were treated with GM-CSF or IL-3, lysed, and subjected to SDS-PAGE. Specific bands were excised and inserted into contiguous slots of a 15% acrylamide gel, and 15 pL of Stuphylococcus oureus V8 protease (Sigma; 0.5 mg/mL) was added to each slot. The protein mixture Gel electrophoresis ond immunoblotting.
Merobolic labeling ond peptide mopping.
was electrophoresed until the bromophenol bluedye front reached the interface between the stacking gel and the resolving gel. At this point electrophoresis was stopped for I hour. Digested fragments were then separated by SDS-PAGE. Thegels were then immunoblotted for phosphotyrosine-containing peptides. The anti-phosphotyrosine antibody was then detected with the combination of purified rabbit antimouse Ig (Dako. Santa Barbara, CA) and '"I-donkey antirabbit Ig (Amersham). In separate experiments. M07E cells (3 x IO") were labeled in I-mL of phosphate-free RPMl 1640 containing 0.5% BSA and 1 mCi of carrier-free '2P-orthophosphate (Amersham, Arlington Heights, IL) for 4 hours. Labeled cells were stimulated with or without growth factors a t 37OC for IO minutes, washed with PBS, and lysed. The lysates were subjected to S uureus V8 protease mapping as above. The second-stage gels were then stained. destained. and analyzed by autoradiography.
RESULTS
GM-CSF and IL-3 induce rapid protein-tyrosinephospho-
rylation of cellular proteins. M 0 7 E cells were removed from growth factor for 6 to 18 hours and then treated with physiologic concentrations of GM-CSF, IL-3, G-CSF, M-CSF. or other cytokines for IO minutes. Changes in tyrosine phosphorylation were detected by Western blotting with a MoAb specific for phosphotyrosine (Fig I) . Increased phosphotyrosine was observed in proteins particularly a t mol wt 93,000 and 70,000 (pp93 and pp70. respectively) after both GM-CSF or IL- The phosphorylation of both pp93 and pp70 was dasc dependent. with readily detectable activity at 1.0 ng/mL GM-CSF and maximal activity at 10 ng/mL (Fig 2A) . IL-3 activity was alsodetectable at 1.0 ng/mL but maximal at 30 ng/mL (Fig 2R and data not shown) . M07E cells were exposed to GM-CSF for IO minutes and then crudely fractionated into membrane-enriched and cytoplasm-cnriched fractions (Fig 3) . Both pp93 and pp70 were enriched in the cytoplasm fraction and depleted in the membrane fraction.
GM-CSF and IL-3 induce tyrosine phosphorylation of an owrlapping set of substrates. Simultaneous expasure of M07E cells to optimum concentrations of both GM-CSF and IL-3 did not increase the amount of pp93 visualized on the phosphotymine immunoblot compared to either factor alone. suggesting that phosphorylation of two proteins of identical appnnnt molecular mas.. was unlikely (data not shown). Isoelectric focusing was technically unsatisfactory bccause several proteins. notably pp93. failed to enter the focusing gel. Therefore a two-dimensional gel system. in which the first dimension is run under nonreducing conditions and the second dimension is run under reducing conditions. was used to further show the overall similarity of the pattern of tynmine phosphorylation induced by GM-CSF or It--3 (Fig 4) . This gel system rcsolved pp93 into t h m distinct spots. An identical pattern was observed after either GM-CSF or IL-3 stimulation. One of the spots was appmximately 200 Kd under nonreducing conditions and 93 Kd under reducing conditions, suggesting the possibility that it was either a homodimer or complexcd to another protein through a reducible bond. The other two spots were 90 to 95 Kd under both reducing and nonrcducing conditions. The relationship of these three spots to each other is currently under investigation.
In an elTort to further compare the tyrosine phosphorylation substrates of GM-CSF and IL-3. additional studies of pp93 were undertaken beatuse of the high abundance of this particular phosphoprotein in CSF-treated M 0 7 E cells. The pp93 band was excised from a onedimensional gel. and the eluted proteins were digested with staphylococcal V8 proteas~. The digestion products were separated on a second reducing gel and immunoblotted (Fig 5) . The phosphotymine pcptide maps of the 93-Kd region after both GM-CSF and IL-3 treatment were identical. Also. M 0 7 E cells were labeled in vivo with "P orthophosphate. stimulated with Time course of CSF-induced protein-tyrosine phasphorylorion. The kinetics of protein-tyrosine phosphorylation induced by GM-CSF and IL-3 were similar (Fig 6A and B) . Peak levels of phosphorylation were observed after GM-CSF at 5 minutes and at 5 to IS minutes after IL-3 in multiple experiments. Phosphorylation of pp93 was detectable as early as 30 seconds after GM-CSF and I minute after IL-3 (data not shown). Tyrosine phosphorylation patterns returned to baseline at 90 to I20 minutes (data not shown).
Eflkcrs of sodium orrhovanadate on CSF-induced tym i n e phmphorylarion. Vanadate is an inhibitor of many PTPasekmU The effects of vanadate on GM-CSF-and IL-3-inducccl protein-tyrosine phosphorylation were evaluated by culturing factordeprived MO7E cells with IO pmol/L vanadate for 2 hours. Factor was then added and immunoblot analysis performed over the next 0 to60 minutes (Fig 6) . Treatment of cells with vanadate by itself resulted in very little change in the phosphorylation of most phosphoproteins Over the total 3-hour period of this study. Figure 6 KANAUURA ET M shows the effects of vanadate alone at 2 hours (the " 0 time after factor addition). Increased tyrosine phosphorylation of pp70. pp63. and ppS5 were Ken in some cxperiments following treatment with vanadate alone (compare "0" time points in control-and vanadate-treated cells). No increase in tyrosine phosphorylation of pp130. ppl25. or pp93 was detected with this method (Fig 6) (Fig 6) . For example. tyrosine phosphorylation of pp70 in the absence of vanadate peaked at 5 minutes and declined rapidly thereafter in the absence of vanadate. However. in the presenceof vanadate. pp70 tyrosine phosphorylation of pp70 peaked at 30 minutes and declined at 60 71 1 minutes in multiple experiments (Fig 6) . For other proteins, however. vanadate had a greater effcc~ on degree of phosphorylation than on duration of phosphorylation (compare pp93 phosphorylation in Fig 6h and 6R) . Thcse results are consistent with the known activity of vanadate as an inhibitor of tyrosine phosphatases. Additionally the increased degree of tyrosine phosphorylation observed in Fig 6 facilitate comparison of the effcc~s of GM-CSF and IL-3. again demonstrating the near identity of the effects of thesc two factors on protein-tyrosine phosphorylation.
Eflccts of vanadarc on M07E cell proliferation. Since vanadate treatment increases the degree of GM-CSF-and IL-3-induced protein-tyrosine phosphorylation, the effects of vanadate treatment on GM-CSF and IL-3-induced cellular proliferation were investigated. M07E cells were cultured in the presence of 0 to 20 rmol/L sodium orthovanadate and 0 to 31.6 ng/mL GM-CSF or 0 to 316 ng/mL IL-3 for 72 hours. followed by measurement of cell proliferation (Fig 7) .
Vanadate by itself had a minimal effm on the proliferation of M07E cells but significantly increased GM-CSF-and IL-3depcndent prolifctation in each of three scparatcexperiments (P < .01). At I ng/mL of GM-CSF. for example. For experiments not shown, the MTT assay2' was shown to accurately measure cell number in the presence or absence of vanadate; furthermore, the results of the MTT assay shown in Fig 7 were confirmed by counting cells and by measuring 'H-thymidine incorporation. These results are consistent with the hypothesis that the induction of tyrosine-kinase activity by these factors is associated with proliferation. The effects of vanadate were dose dependent with maximum activity at 10 rmol/L, a concentration that was shown to have significant effects on protein-tyrosine phosphorylation (Fig 6) . Higher concentrations of vanadate were inhibitory to cell growth (Fig 7) .
Tyrosine phosphorylation in normal myeloid cells and factor-independent leukemic cell lines. Using immunoblot analysis, readily detectable increased phosphorylation of pp93 in response to GM-CSF was observed in normal monocytes, neutrophils, and the leukemic cell lines THP-1 and JOSK-M but not in HL-60 cells (data not shown). Phosphorylation of pp93 was increased in 10/10 cases of primary AML treated with GM-CSF (10 ng/mL) for 10 minutes, and in 5/6 cases treated with IL-3 (10 ng/mL; data not shown). Normal bone marrow mononuclear cells did not have detectable phosphotyrosine in pp93, but treatment of cells with GM-CSF resulted in a detectable level. These results show that at least some of the common substrates for GM-CSF-and IL-3-induced tyrosine phosphorylation identified in the M07E cell line are observed in response to CSF stimulation of other types of myeloid cells.
DISCUSSION
The diverse effects of GM-CSF and IL-3 on proliferation, differentiation, and activation of both mature and immature hematopoietic cells are mediated through binding of these factors to high-affinity surface receptors. The mechanisms of signal transduction of the GM-CSF and IL-3 receptors are largely unknown. In this study we have investigated the effects of these two factors on tyrosine-kinase activity in a unique human megakaryoblast cell line, M07E, which expresses functional receptors for both GM-CSF and IL-3 and requires physiologic concentrations of either factor for viability and g r o~t h .~' The results show that exposure of factor-deprived cells to either GM-CSF or IL-3 induces rapid (less than 1 minute) tyrosine phosphorylation of a closely related, or identical, set of proteins. Tyrosine phosphorylation of two proteins was particularly prominent, pp70 and pp93. Tyrosine phosphorylation of pp93 and pp70 was unique to GM-CSF and IL-3 and was not observed after treatment of these cells with G-CSF, M-CSF, TNF, interferon-y, IL-1, IL-4, IL-6, TGF-8, or PMA. The apparent similarity of the proteins that are phosphorylated on tyrosine residues in response to either GM-CSF or IL-3 was observed in one-dimensional and two-dimensional immunoblots and both before and after pretreating the cells with the phosphatase inhibitor vanadate to enhance the immunoblot signals. Furthermore, peptide mapping of the 93-Kd band with Staphylococcus V8 protease was carried out, again demonstrating identity of the effects of GM-CSF and IL-3 in this cell line. These results show that both GM-CSF and IL-3 induce protein tyrosine phosphorylation of an apparently overlapping set of substrates.
We also present data that suggest that GM-CSF-and IL-3-induced tyrosine kinase activity may be important for the proliferation of these cells. This suggestion is based on several observations. First, the tyrosine kinase activity is rapidly induced (1 minute or less after factor addition to the medium), which is typical for other growth factor receptors where signal transduction is mediated by tyrosine kinase activity, such as the PDGF and CSF-1 receptor^.^'.^^ Second, the dose-response curves for proliferation and for tyrosine kinase activity are similar (compare Figs 2 and 7) . Finally, For personal use only. on October 3, 2017. by guest www.bloodjournal.org From pretreatment of M07E cells with the tyrosine-phosphatase inhibitor vanadate results in enhanced factor-dependent tyrosine phosphorylation of multiple substrates and also reproducibly results in enhanced factordependent cell growth. Vanadate has been widely used to investigate the effects of protein-tyrosine phosphatases in signal t r a n s d~c t i o n~@~~ and has been used to demonstrate the role of PTPase's in dephosphorylation of receptors for insulin:' insulin-like growth factor, and epidermal growth factor. 36 Our results with vanadate pretreatment of M07E cells are consistent with inhibition of one or more PTPase. The results in Fig 6 show that vanadate treatment has a profound effect on the tyrosine-kinase activity induced by either GM-CSF or IL-3 but little effect on tyrosine-kinase activity in the absence of these factors. Furthermore, vanadate by itself did not induce cell proliferation of M07E cells. Thus vanadate is not directly inducing a tyrosine-kinase activity in M07E cells, and the increased protein tyrosine phosphorylation observed in Fig 6 is most likely due to inhibition of PTPase activity. However, direct studies of the effects of vanadate on specific PTPase's in hematopoietic cells are necessary. It is also possible that vanadate is stimulating some cellular process unrelated to tyrosine phosphorylation that is responsible for cell proliferation, and studies with other phosphatase inhibitors are warranted. M07E cells have been shown to express high levels of at least one isoform of a known PTPase, CD45.25 In lymphoid cells, CD45 has been shown to dephosphorylate the tyrosine-kinase p p 5 6 1~k ?~*~ Furthermore, CD45 is known to be inhibitable by vanadate.40 Thus our data suggest that direct studies of the role of CD45 and other PTPase's in M07E cells may be important in understanding growth regulation of hematopoietic cells.
Our data suggest that induction of tyrosine-kinase activity is important in the signal-transduction pathway for CSFinduced proliferation, and one or more of the substrate proteins may serve as intermediate messengers in linking the surface receptors to control of proliferation in the nucleus. As noted above, two proteins were prominently phosphorylated, and at least six other proteins were variably phosphorylated on tyrosine within 5 minutes of CSF addition. It is likely that some substrate proteins are not related to mitogenesis but stimulate other cellular processes. For example, GM-CSF and IL-3 induce similar tyrosine phosphorylation of pp93, but the mitogenic response to both factors is different (Fig 7) . Thus phosphorylation of pp93 may not directly correlate with the mitogenic signal. In comparing our observations in human cells to those of others in murine cells, some potentially common substrate proteins can be identified. For example, IL-3 was reported to induce tyrosine phosphorylation of both a 90-and 95-Kd protein in the IC-2.9 cell line, as well as phosphorylation of proteins of 160, 70, and 55 Kd. Kd are commonly observed in response to GM-CSF and/or IL-3. However, it is possible that multiple tyrosine-kinase substrates are found in these molecular weight ranges, and direct comparison of these proteins will need to been done by peptide mapping or immunoprecipitation when appropriate antibodies are available.
Despite the fact that an increasing number of growthfactor receptors have been shown to be tyrosine kinases or to be associated with rapid induction of tyrosine kinase activity," very few substrates for these receptor-associated kinases have been identified. Platelet-derived growth factor stimulates the tyrosine phosphorylation of an 85-Kd protein that may be a phophatidylinositol (PI) kinase."2 Transformation of 3T3 cells with v-fms also results in enhanced tyrosine phosphorylation of 85-Kd and increased PI kinase activity. 42 Expression of v-fms, v-src, or v-sis in 3T3 cells or treatment of 3T3 cells with PDGF or EGF induces phosphorylation and activation of Raf-1 (c-run, a serine/threonine protein kinase of mol wt 74,000.43 It is possible that the pp70 described here is c-ruJ and experiments to test that possibility are currently underway. Preliminary data from others suggest that c-ruf may be phosphorylated in response to IL-3 in some murine cell lines." Activation of the EGF receptor has been shown to lead to tyrosine phosphorylation and activation of phospholipase C.45*46 Finally, the GTPase-activating protein, GAP (mol wt = 125,000), is phosphorylated on tyrosine in cells transformed by v-src or v-fps or in fibroblasts in response to activation of the epidermal growth factor re~eptor.~' The potential identity of these known tyrosine-kinase substrates with the proteins observed in this study is currently being investigated.
A cDNA encoding a low-affinity GM-CSF binding protein has recently been cloned from a human placental library.23 This receptor does not bind IL-3 but does have some homology to a family of factor receptors including the eyrthropoietin, IL-6, and IL-2 receptors.23 Similarly, a cDNA encoding a low-affinity murine IL-3 receptor has been cloned.24 Neither of these proteins has the structure typical of a tyrosine kinase. It is not known at this time if these are the only GM-CSF and IL-3 receptors. If these receptors are representative of the functional GM-CSF and IL-3 receptors on M07E cells, our results would suggest that they induce rapid activation of one or more intracellular tyrosine kinases such as c-fes, c-abl, c-src, c-hck, etc, and further that the GM-CSF and IL-3 receptors may activate the same tyrosine kinases. It is possible, for example, that the receptors exists in For personal use only. on October 3, 2017. by guest www.bloodjournal.org From a complex with a tyrosine kinase or are coupled to a kinase through an intermediate step of signal transduction such as activation of a G protein. Further studies will be necessary to define the nature of the receptors for these factors and how they induce tyrosine kinase activity. We also suggest, based on preliminary studies with vanadate, that the function of this receptor/kinase complex may be modulated by one or more PTPases and that events that regulate PTPase activity could be important in regulating growth of some types of hematopoietic cells.
